Tubular Breast Cancer Stage II Completed Phase 2 / 3 Trials for Doxorubicin (DB00997)

Also known as: Tubular breast carcinoma / Tubular breast cancer

IndicationStatusPhase
DBCOND0053760 (Tubular Breast Cancer Stage II)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01426880Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerTreatment